Market Size of Total Iron Binding Capacity Reagents Industry
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 355.30 Million |
| Market Size (2029) | USD 447 Million |
| CAGR (2024 - 2029) | 4.70 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Total Iron Binding Capacity Reagents Market Analysis
The Total Iron Binding Capacity Reagents Market size is estimated at USD 355.30 million in 2024, and is expected to reach USD 447 million by 2029, growing at a CAGR of 4.70% during the forecast period (2024-2029).
Factors such as the rising patient pool suffering from iron deficiency and increasing R&D expenditure are expected to boost the market growth during the forecast period.
The increasing prevalence of iron deficiency anemia has driven the growth of the total iron-binding capacity reagent markets. Iron deficiency anemia is common in women's population due to the menstrual cycle, boosting the total iron binding capacity (TIBC) reagents market. For instance, according to the Ministry of Health and Family Welfare December 2022 update, the prevalence of anemia among six groups was 25.0% in men and 57.0% in women aged 15-49 years) and 31.1% of adolescent boys (15-19 years) in the last two years.
In addition to the above context, about 59.1% of adolescent girls were suffering from iron deficiency, followed by 52.2% in pregnant women (15-49 years) and 67.1% in children (6-59 months). Thus, the increasing burden of iron deficiency anemia among the population requires effective diagnosis, which is expected to fuel the market growth during the forecast period.
Moreover, various research studies were conducted to compare different methods of TIBC estimation and to correlate the TIBC values obtained by different methods with serum TF concentration. For instance, as per the article published in August 2022 in Thieme journal, the means of TIBC by calculated, indirect, and direct methods were 344.51, 342.23, and 378.24 µg/dL, respectively. The study showed that the direct method of TIBC is more dependable for diagnosing serum transferrin (TF) levels than other methods. This is expected to increase the use of the direct TIBC method for estimating total iron binding capacity (TIBC), leading to market growth.
Hence, due to the high prevalence of iron deficiency diseases and the rise in research and development utilizing total iron binding capacity reagents, the market is expected to grow significantly during the forecast period. However, limited product availability and the time-consuming nature of the TIBC assays are expected to restrain the market growth.
Total Iron Binding Capacity Reagents Industry Segmentation
As per the scope of the report, total iron binding capacity is the test used to measure the blood capacity to bind iron with transferrin. TIBC indicates iron status; elevated when iron is low; helpful in diagnosing and monitoring iron deficiency anemia and late pregnancy iron deficiency.
The total iron binding capacity reagents market is segmented by disease type, end user, and geography. By disease type, the market is segmented by iron deficiency anemia, iron deficiency in late pregnancy, and other disease types. By end user, the market is segmented by hospitals, clinics, and other end users. By geography, the market is divided into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report offers the value (USD) for the above segments.
| By Disease Type | |
| Iron Deficiency Anemia | |
| Iron Deficiency in Late Pregnancy | |
| Other Disease Types |
| By End User | |
| Hospitals | |
| Clinics | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Total Iron Binding Capacity Reagents Market Size Summary
The total iron binding capacity (TIBC) reagents market is poised for growth, driven by the increasing prevalence of iron deficiency anemia and the resurgence of laboratory services post-COVID-19. The pandemic had previously disrupted the supply chain, affecting the availability of essential laboratory reagents. However, as healthcare systems stabilize, the demand for TIBC reagents is expected to rise, fueled by the need for effective diagnosis of iron deficiency anemia, particularly among women and vulnerable populations. The market is also benefiting from ongoing research and development activities that utilize these reagents, as studies continue to explore innovative diagnostic methods and correlations with serum iron levels. Despite challenges such as limited product availability and the complexity of TIBC assays, the market is set to expand, supported by strategic initiatives from key players and increasing healthcare expenditures.
North America is anticipated to hold a significant share of the TIBC reagents market, attributed to the high prevalence of iron deficiency anemia and robust research and development efforts in the region. The demand for accurate diagnosis and treatment options is driving market growth, with studies highlighting the prevalence of iron deficiency even among those receiving prenatal supplements. The market's consolidation is evident with major companies like Randox Laboratories, Biosystems SA, and Thermo Fisher Scientific leading the charge. Additionally, strategic activities such as product launches and collaborations are expected to further propel market expansion. As awareness campaigns and healthcare initiatives continue to address anemia prevention, the TIBC reagents market is poised for substantial growth over the forecast period.
Total Iron Binding Capacity Reagents Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Patient Pool Suffering from Iron Deficiency
-
1.2.2 Increasing R&D Expenditure
-
-
1.3 Market Restraints
-
1.3.1 Limited Product Availability and Time Consuming Nature of the TIBC Assays
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD)
-
2.1 By Disease Type
-
2.1.1 Iron Deficiency Anemia
-
2.1.2 Iron Deficiency in Late Pregnancy
-
2.1.3 Other Disease Types
-
-
2.2 By End User
-
2.2.1 Hospitals
-
2.2.2 Clinics
-
2.2.3 Other End Users
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Total Iron Binding Capacity Reagents Market Size FAQs
How big is the Total Iron Binding Capacity Reagents Market?
The Total Iron Binding Capacity Reagents Market size is expected to reach USD 355.30 million in 2024 and grow at a CAGR of 4.70% to reach USD 447 million by 2029.
What is the current Total Iron Binding Capacity Reagents Market size?
In 2024, the Total Iron Binding Capacity Reagents Market size is expected to reach USD 355.30 million.
